Follow-Up Q & A Webinar: Opioid Use Disorders: The Female Experience. Ashley Braun-Gabelman, Ph.D. University Hospitals Case Medical Center
|
|
- Roderick McBride
- 5 years ago
- Views:
Transcription
1 Follow-Up Q & A Webinar: Opioid Use Disorders: The Female Experience Ashley Braun-Gabelman, Ph.D. University Hospitals Case Medical Center 1
2 Ashley Braun-Gabelman, Disclosures No disclosures 2
3 Planning Committee, Disclosures AAAP aims to provide educational information that is balanced, independent, objective and free of bias and based on evidence. In order to resolve any identified Conflicts of Interest, disclosure information from all planners, faculty and anyone in the position to control content is provided during the planning process to ensure resolution of any identified conflicts. This disclosure information is listed below: The following developers and planning committee members have reported that they have no commercial relationships relevant to the content of this webinar to disclose: AAAP CME/CPD Committee Members Dean Krahn, MD, Kevin Sevarino, MD, PhD, Tim Fong, MD, Tom Kosten, MD, Joji Suzuki, MD; and AAAP Staff Kathryn Cates-Wessel, Miriam Giles, and Justina Andonian. All faculty have been advised that any recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in the presentation must conform to the generally accepted standards of experimental design, data collection, and analysis. The content of this CME activity has been reviewed and the committee determined the presentation is balanced, independent, and free of any commercial bias. Speakers must inform the learners if their presentation will include discussion of unlabeled/investigational use of commercial products. 3
4 Target Audience The overarching goal of PCSS-O is to offer evidence-based trainings on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction. Our focus is to reach providers and/or providers-in-training from diverse healthcare professions including physicians, nurses, dentists, physician assistants, pharmacists, and program administrators. 4
5 Educational Objectives At the conclusion of this activity participants should be able to: Identify changing demographics of heroin and opioid use disorders Recognize barriers to treatment Discuss gender-related treatment issues Describe co-occurring disorders Identify treatment options for pregnant women 5
6 Outline Changing demographics of OUD Course of illness Treatment issues Barriers to treatment Co-occurring disorders Pregnancy 6
7 Case Vignette #1: Kelly Caucasian, 45 y/o presents with Heroin Use Disorder, severe Childhood sexual abuse, incest, poverty, neglect Strong family h/o addiction First given tramadol by brother Mother s little helper 7
8 Case Vignette #1: Kelly Now self-described Soccer Mom Married mother of 2 teenage daughters Manager at work I needed to use to be able to get everything done. 8
9 Case Vignette #2: Jessica 36 y/o, Caucasian, single mother of 3 y/o son and 8 y/o daughter Works as RN Nominated for Nurse of the Year Award Diverting Oxycodone from work Mother recovering alcoholic The pills made me feel competent, energetic. 9
10 Changing Demographics of Opiate Users Currently, about 1/3 of those with opioid dependence are women of child-bearing age (Unger et al. 2010) January 17, 2016 NY Times: The death rates of Caucasians, especially women, are rising (death rates for black and Hispanics continue to fall) Drug overdose New users predominantly white, living in nonurban areas 75% current heroin users began with Rx opioids first 10
11 Epidemiology The demographics of those who abuse heroin and other opiates has changed in recent years (Cicero, 2014) 1960s: mostly men abusing heroin Now: men and women Cicero, Ellis, Surratt, Kurtz (2014) 11
12 Prescription Opioids Mixed findings Several large scale studies found women more likely to use and abuse prescription opioids (CDC, 2016; Green et al., 2009, Rosenblum et al., 2007; Simoni-Wastila et al., 2000,2004, c.f. Back et al., 2010 In contrast, 2013 and 2014 NSDUH nonmedical use of pain medication still higher among men Rx misuse and overdose among women rapidly rising 12
13 Rx Opioids In the past two decades, opioid prescriptions have increased overall Women tend to be prescribed medication with abuse potential more often than men (Isacson and Bingefors, 2002; Simoni- Wastila, 2004) Women prescribed opiates more often than men (Anthony, 2008; Gu, 2010; McCabe et al., 2005; Parsells, 2008; Roe, 2003; Zhong 2013) More chronic pain (Wiesenfeld-Hallin, 2005) Lower pain tolerance (Berkley, 1997; Dixon et al., 2004) 13
14 Heroin Men still more likely to use heroin but women s use rapidly rising o Men and women equally likely to inject 14
15 Injection Drug Use Injection drug use in particular related to partner drug use (Powis et al. 1996) Women who inject heroin often have partner who also injects Women more likely to be introduced to injection by male partner Women more likely to share needles, leading to higher risk of infection (Maher et al. 2006) 15
16 Telescoping A faster course from commencing substance use to SUD and treatment onset More rapid progression of the disease more drug-related problems, sooner Several studies indicate a telescoping course for women with OUD 16
17 Treatment Women less likely to go to treatment compared to men Gender not predictive of LOS or outcome (Greenfield et al., 2007) 17
18 Children: Barrier to Treatment Women more likely to have children to care for (Bawor et al., 2015) Barriers to treatment Who will care for children while mother is in treatment? Many worry about custody issues (Greenfield et al., 2010) Mothers who are primary caretakers of the children may leave treatment early or not go at all due to childcare restraints (Castillo & Waldorf, 2008) 18
19 Children: Motivator for Treatment Evidence that women who live with their children more likely to go to treatment (Greenfield et al., 2010) Women who are able to have children with them in treatment or maintain custody, more likely to stay in treatment (Greenfield et al., 2010) 19
20 Other Barriers Women often caretakers, both at home and in caretaking professional roles (nurses, social services, etc.) Women in leadership roles at home and at work It can be a difficult role-shift to ask for help, accept help Shame Associated with relapse among women (Wiechelt & Sales, 2001) 20
21 Question How to motivate women to seek and sustain treatment? Whenever possible, reducing practical barriers including childcare Motivation to seek treatment: Often from primary care, welfare and other community agencies A non-judgmental approach allows women to be more open, reduce shame and stigma 21
22 Question Motivation to sustain treatment Motivational Interviewing Strengthen patient s own motivation to change Elicit and encourage change talk OARS Non-confrontational, compassionate, collaborative 22
23 Question When should children be removed from home/parent? Safety of child Move to a safe family member if possible Consult with experts in social work and/or law 23
24 Case Example 32 y/o single mother of 5 y/o boy and 3 y/o girl Father of children is in prison Patient is charged with attempting to sell drugs from her car while children are in the backseat Patient is mandated to treatment Children to live with patient s mother Patient s mother becomes legal guardian At least 6 months sobriety required to reassess 24
25 Medication Treatment Medication: Methadone, Buprenorphine, Naltrexone Consider gender-specific issues Different opioid binding capacity Hormone levels 25
26 Psychosocial Treatment In early recovery: Coping skills, problem-solving Meditation and breathing techniques Psychoeducation Motivational Interviewing Cognitive Behavioral Therapy Relapse Prevention Couples and Family 26
27 Question Are there structured support groups for recovering women? AA/NA women s groups Women s groups at specific treatment centers 27
28 Co-occurring Conditions Compared to men, women with OUD more likely to have: More physical health problems Family history of psychiatric illness Co-occurring psychological distress compared to men (Back, 2010; Green et al., 2009) 28
29 Psychiatric Comorbidity Anxiety Disorders PTSD, OCD Mood Disorders Major depression Dysthymia Manic Disorder (Grella et al., 2009) Eating Disorders Bulimia Disordered eating Borderline Personality Disorder 29
30 Co-Occurring Disorders Treatment Many symptoms of acute and post-acute withdrawal are also common to other mental health conditions: Anxiety, nervousness Insomnia Depressed mood Difficulty concentrating Important for treating clinician to differentiate and treat appropriately 30
31 Maternal Opioid Use is Increasing Opiate use among pregnant women 1.19 (2000) to 5.63 (2009) per 1000 hospital births per year Neonatal Abstinence Syndrome 1.20 (2000) to 3.39 (2009) per 1000 hospital births per year (Patrick et al., 2012) 31
32 Heroin During Pregnancy Heroin use during pregnancy associated with many adverse effects on fetus Short half-life, effects may be due to repeated withdrawal in the fetus Take into account lifestyle effects of some women actively using heroin Prostitution, theft, violence, STI s 32
33 Treatment of Pregnant Women Opioid withdrawal should be avoided in pregnant women Goals of MAT in pregnant women: Reduce risks of illicit opioid use and withdrawal Encourage prenatal care and treatment Reduce criminal activity Avoid associated risks 33
34 MOTHER Study Jones et al Methadone vs. buprenorphine in pregnant women Outcomes: Buprenorphine has similar maternal outcomes to methadone Buprenorphine resulted in less severe neonatal abstinence syndrome 34
35 Opioid Rx in Pregnant Women If an opioid dependent pregnant woman is Stable on single agent buprenorphine Remain on single agent buprenorphine Stable on Suboxone Switch to single agent buprenorphine Stable on methadone Remain on methadone* Naïve to agonist therapy Consider buprenorphine due to lower NAS severity *unless reason to switch to buprenorphine, e.g., moving to location without access to methadone clinic Risk of precipitated withdrawal, vulnerability to illicit drug use 35
36 Opioid Rx in Pregnant Women Always consider full medical and psychological history Assess dosage throughout pregnancy and adjust as necessary Inadequate dose may lead to withdrawal symptoms, fetal distress, vulnerability to use illicit drugs 36
37 Question Please discuss the connection between opiate medication combined with the epidural during childbirth and previous and/or future addiction. 37
38 Analgesia During Labor Women on methadone or buprenorphine should be offered analgesia options (epidural/spinal anesthesia) Maintenance dose not adequate for pain relief Avoid agonist-antagonist may precipitate withdrawal Women taking methadone should not be given buprenorphine 38
39 Analgesia During Labor Higher dose often needed for women on maintenance medication Continue regular daily dose of maintenance medication to prevent withdrawal Breastfeeding safe and encouraged Minimal levels of methadone and buprenorphine in breast milk 39
40 Question: OUD and Pain OUD and chronic pain commonly co-occur Women have: More chronic pain (Wiesenfeld-Hallin, 2005) Lower pain tolerance (Berkley, 1997; Dixon et al., 2004) Opiate pain medication should be avoided For individuals on maintenance medication, in the case of surgery, medical team should be notified and plan formulated 40
41 OUD and Pain Effective, non-pharmacological treatments for pain Psychoeducation Mindfulness exercises CBT cognitive restructuring activity pacing Grounding 41
42 Summary Women progress from first use to problem use faster than men Women more likely to have co-occurring physical or mental health condition Despite faster course, faster time to develop problems associated with opioid use, and more co-occurring disorders, women less likely to enter treatment compared to men Gender is not predictive of LOS or outcome 42
43 Summary Must take into account co-occurring disorders Special considerations for pregnant women 43
44 Additional Questions Could you address using while on methadone? Different treatment programs address this differently Total abstinence vs. harm reduction May indicate need for higher LOC 44
45 Additional Questions Info on changing standards for prescribing opioids. CDC Guideline for Prescribing Opioids for Chronic Pain United States, 2016 Recommendations and Reports / March 18, 2016 / 65(1); e1.htm 45
46 Additional Questions What are the studies identifying about the relapse statistics after a methadone maintenance program? According to California Society of Addiction Medicine, methadone maintenance success rates range from 60-90% Longer time in treatment, better outcomes Best outcomes when combine medication with psychosocial treatment 46
47 References Anthony M, Lee KY, Bertram CT, Abarca J, Rehfeld RA, Malone DC,... Woosley RL (2008). Gender and age differences in medications dispensed from a national chain drugstore. Journal of Women's Health, 17(5): Back SE, Lawson KM, Singleton LM, Brady KT (2011). Characteristics and correlates of men and women with prescription opioid dependence. Addictive Behaviors, 36: Back S., Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L.,... Lin W (2011). Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.the American journal of drug and alcohol abuse, 37(5): Bawor M., Dennis BB, Varenbut M, Daiter J, Marsh DC, Plater C,... Desai D. (2015). Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study. Biology of sex differences, 6(1): Berkley KJ.(1997). Sex differences in pain. Behavioral and Brain Sciences, 20: Bernstein J, Derrington TM, Belanoff C, Cabral HJ, Babakhanlou-Chase H, Diop H,... Kotelchuck M (2015). Treatment outcomes for substance use disorder among women of reproductive age in Massachusetts: A populationbased approach. Drug and alcohol dependence, 147: Castillo DT, Waldorf VA (2008). Ethical issues in the treatment of women with substance abuse. The book of ethics: Expert guidance for professionals who treat addiction, Centers for Disease Control and Prevention (CDC). Prescribing Data. (2016, March 16). Retrieved April 10, 2016, from Centers for Disease Control and Prevention (CDC). Prescription painkiller overdoses: a growing epidemic, especially among women (2013, July.) Retrieved April 11, 2016 from Cicero TJ, Ellis MS, Surratt HL, Kurtz, SP (2014). The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA psychiatry, 71(7): Dixon KE, Thorn BE, Ward LC (2004). An evaluation of sex differences in psychological and physiological responses to experimentally-induced pain: a path analytic description. Pain, 112(1): Green TC, Grimes Serrano JM, Licari A, Budman SH, Butler SF. (2009). Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug and Alcohol Dependence, 102 (1-2): Greenfield SF, Back SE, Lawson K, Brady KT (2010). Substance Abuse in Women. Psychiatric Clinics of North America, 33:
48 References Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK.,... Miele, G. M. (2007). Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and alcohol dependence, 86(1): Grella CE, Karno MP, Warda US, Niv N, Moore AA (2009). Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addictive behaviors, 34(6): Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for NCHS Data Brief. 2010:1 8. Hölscher F, Reissner V, Di Furia L, Room R, Schifano F, Stohler R,... Scherbaum N (2010). Differences between men and women in the course of opiate dependence: is there a telescoping effect?. European archives of psychiatry and clinical neuroscience, 260(3): Isacson D, Bingefors K. (2002). Epidemiology of analgesic use: a gender perspective. European Journal of Anaesthesiology, 19: Jones HE, Finnegan LP, Kaltenbach K (2012). Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs, 72(6): Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, Sargent PL (2006). Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction, 101(10): McCabe, S, Knight JR, Teter CJ, Wechsler H. (2005). Non medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction, 100(1): Parsells KJ, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. (2008) Prevalence and characteristics of opioid use in the US adult population. Pain, 138: Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, Jama,307(18): Peles E, Adelson M, Seligman Z, Bloch M, Potik D, Schreiber S (2014). Psychiatric comorbidity differences between women with history of childhood sexual abuse who are methadone-maintained former opiate addicts and non-addicts. Psychiatry research, 219(1): Peles E, Weinstein A, Sason A, Adelson M, Schreiber S. (2014). Stroop task among patients with obsessivecompulsive disorder (OCD) and pathological gambling (PG) in methadone maintenance treatment (MMT). CNS spectrums, 19(06): Roe CM, McNamara AM, Motheral BR. (2002). Gender- and age-related prescription drug use patterns. Annals of Pharmacotherapy, 36:
49 References Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM,... Haddox JD (2007). Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and alcohol dependence, 90(1): Ross J, Ross J, Teesson M, Ross J, Teesson M, Darke S,... Ross J. (2005). The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug and alcohol review, 24(5): Shah NG, Lathrop SL, Reichard RR, Landen MG (2007). Unintentional drug overdose death trends in New Mexico, USA, : Combinations of heroin, cocaine, prescription opioids and alcohol. Addiction, 103: Simoni-Wastila L. (2000). The use of abusable prescription drugs: the role of gender. Journal of women's health & gender-based medicine, 9(3): Simoni-Wastila L., Ritter G., Strickler G. (2004). Gender and other factors associated with the nonmedical use of abusable prescription drugs.substance use & misuse, 39(1): Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) Rockville, MD: Substance Abuse and Mental Health Services Administration, Unger A, Jung E, Winklbaur B, Fischer, G. (2010). Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. Journal of addictive diseases, 29(2), Wiechelt SA, Sales E. (2001). The role of shame in women's recovery from alcoholism: The impact of childhood sexual abuse. Journal of Social Work Practice in the Addictions, 1(4): Wiesenfeld-Hallin Z. (2005). Sex differences in pain perception. Gender Medicine, 2: Zhong W, Maradit-Kremers H, St. Stauver JL, Yawn BP, Ebbert JO, Roger VL (2013). Age and sex patterns of drug prescribing in a defined American population. Mayo Clinic Proceedings, 88: Zweben, J. E. (2003). Special issues in treatment: Women. Principles of addiction medicine, 3111:
50 PCSS-O Colleague Support Program and Listserv PCSS-O Colleague Support Program is designed to offer general information to health professionals seeking guidance in their clinical practice in prescribing opioid medications. PCSS-O Mentors comprise a national network of trained providers with expertise in addiction medicine/psychiatry and pain management. Our mentoring approach allows every mentor/mentee relationship to be unique and catered to the specific needs of both parties. The mentoring program is available at no cost to providers. For more information on requesting or becoming a mentor visit: Listserv: A resource that provides an Expert of the Month who will answer questions about educational content that has been presented through PCSS-O project. To join pcss-o@aaap.org. 50
51 PCSS-O is a collaborative effort led by American Academy of Addiction Psychiatry (AAAP) in partnership with: Addiction Technology Transfer Center (ATTC), American Academy of Neurology (AAN), American Academy of Pain Medicine (AAPM), American Academy of Pediatrics (AAP), American College of Physicians (ACP), American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), International Nurses Society on Addictions (IntNSA), and Southeast Consortium for Substance Abuse Training (SECSAT). For more information visit: For questions pcss-o@aaap.org Funding for this initiative was made possible (in part) by Providers Clinical Support System for Opioid Therapies (grant no. 5H79TI025595) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department 51 of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Opioid Use Disorders: The Female Experience. Ashley Braun-Gabelman, Ph.D. University Hospitals Case Medical Center
Opioid Use Disorders: The Female Experience Ashley Braun-Gabelman, Ph.D. University Hospitals Case Medical Center 1 Ashley Braun-Gabelman, Disclosures No disclosures 2 Planning Committee, Disclosures AAAP
More informationRates of Opioid Misuse, Abuse, and Addiction in Chronic Pain. Kevin E. Vowles, PhD University of New Mexico
Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain Kevin E. Vowles, PhD University of New Mexico 1 Kevin E. Vowles, Disclosures Consultant, Pfizer Independent Grants for Learning and Change,
More informationAddiction Prediction: Errors from the bedside hurt patients with pain. Objectives. CDC guideline for prescribing OPIOIDS for Chronic Pain
Addiction Prediction: Errors from the bedside hurt patients with pain Renee C.B. Manworren, PhD, APRN, BC, PCNS-BC, AP-PMN, FAAN Director of Nursing Research and Professional Practice Posy and Fred Love
More informationCourse Overview Management of Chronic Pain: A Core Curriculum for Primary Care Providers
Course Overview Management of Chronic Pain: A Core Curriculum for Primary Care Providers Sponsored by PCSS-O American Academy of Addiction Psychiatry Roger Chou, MD 1 About PCSS-O PCSS-O is a national
More informationPain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy. Disclosure. Preview
Providers Clinical Support System for Opioid Therapies (PCSS-O) Webinar March 7, 2017 Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy Wade Delk, Government Affairs Director, ASPMN
More informationPCSS Projects. Kathryn L. Cates-Wessel Executive Director, AAAP PCSS-MAT and PCSS-O PI and Project Director
PCSS Projects Kathryn L. Cates-Wessel Executive Director, AAAP PCSS-MAT and PCSS-O PI and Project Director 1 Educational Objectives At the conclusion of this activity participants should be able to: Describe
More informationNursing Regulatory Boards Efforts to Provide Guidance to Nurses About Mitigating Prescription Medication Abuse/Diversion
Nursing Regulatory Boards Efforts to Provide Guidance to Nurses About Mitigating Prescription Medication Abuse/Diversion Cathy Carlson, PhD, APN, FNP-BC Aaron Gilson, MS, MSSW, PhD Authors Conflicts of
More informationFollow-up Q & A Webinar: The Role of Shame in Opioid Use Disorders
Follow-up Q & A Webinar: The Role of Shame in Opioid Use Disorders Ashley Braun-Gabelman, Ph.D. University Hospitals Case Medical Center Cleveland, Ohio 1 Ashley Braun-Gabelman, No Disclosures Disclosures
More informationOpioid Dependence 101 and Medication Assisted Treatment
Opioid Dependence 101 and Medication Assisted Treatment Dr. Joji Suzuki Director of the Division of Addiction Psychiatry, Brigham & Women s Hospital Assistant Professor of Psychiatry, Harvard Medical School
More informationFinancing Factors for Implementing Medication-Assisted Treatment
Financing Factors for Implementing Medication-Assisted Treatment Jeremy Attermann, MSW, National Council for Behavioral Health Nick Szubiak, LCSW, National Council for Behavioral Health Brad DeCamp, MPA,
More informationMedication and Behavioral Treatment of Substance Use Disorders
Medication and Behavioral Treatment of Substance Use Disorders Brian Fuehrlein, MD, PhD Director, Psychiatric Emergency Room, VA Connecticut and Assistant Professor of Psychiatry, Yale University 1 Brian
More informationOpioids for Pain Treatment in Persons with Opioid Use Disorder. Patricia Pade, MD Seddon R. Savage, MD, MS Melissa Weimer, DO, MCR
Opioids for Pain Treatment in Persons with Opioid Use Disorder Patricia Pade, MD Seddon R. Savage, MD, MS Melissa Weimer, DO, MCR 1 Educational Objectives At the conclusion of this activity participants
More informationManaging Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University
Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management Melissa Weimer, DO, MCR Oregon Health & Science University 1 Educational Objectives At the conclusion of this activity participants
More informationSpirituality and Chronic Pain: Empirical Research Findings and Clinical Applications
Spirituality and Chronic Pain: Empirical Research Findings and Clinical Applications Amy Wachholtz, PhD, MDiv, MS University of Colorado Denver Sept 20, 2016 1 Amy Wachholtz, Disclosures The author declares
More informationThe Opioid-Exposed Woman
The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus
More informationSTOPPING OPIOIDS. William Morrone, DO MS, FACOFP DABAM DAAPM Deputy Chief Medical Examiner & AOAAM June 24, 2015 Noon ET
STOPPING OPIOIDS William Morrone, DO MS, FACOFP DABAM DAAPM Deputy Chief Medical Examiner & AOAAM June 24, 2015 Noon ET 1 William Morrone DO, Disclosures William Morrone, DO has presented numerous programs
More informationOffice-based Treatment of Opioid Dependence with Buprenorphine: Follow-up Q & A Webinar with Case Discussions
Office-based Treatment of Opioid Dependence with Buprenorphine: Follow-up Q & A Webinar with Case Discussions David A. Fiellin, MD Professor of Medicine, Investigative Medicine and Public Health Yale University
More informationPregnancy and Addiction
Pregnancy and Addiction Carl Christensen, MD, PhD, D-FASAM Clinical Associate Professor, OB Gyn & Psychiatry Wayne State University School of Medicine November 16, 2016 1 Educational Objectives At the
More informationCentral Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy
Centers for Disease Control and Prevention Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Jenna Meyer MPH, RNC-MNN, IBCLC Public Health Advisor Therapies for Opioid Dependent
More informationMain Results and Clinical Implications of the X:BOT Trial: XR-Naltrexone vs. Buprenorphine-Naloxone Film
Main Results and Clinical Implications of the X:BOT Trial: XR-Naltrexone vs. Buprenorphine-Naloxone Film July 31 st, 2018 Hosted by John A. Renner, Jr., MD, DLFAPA Professor of Psychiatry Boston University
More informationDisclosures. Target Audience 4/28/2015. The Road Less Traveled: Using Buprenorphine-Naloxone to Treat High-Risk Chronic Pain Patients
The Road Less Traveled: Using Buprenorphine-Naloxone to Treat High-Risk Chronic Pain Patients Patrick Marshalek, MD Jenna Martino, MSN, FNP-C Audrey Royce, MSN, FNP-C Sarah Roy, MSN, RN, CCRN West Virginia
More informationApproach to Use of Opioids in Patients with Low Back Pain Follow-up Q & A Webinar with Case Discussions
Approach to Use of Opioids in Patients with Low Back Pain Follow-up Q & A Webinar with Case Discussions Roger Chou, MD, FACP Professor of Medicine Oregon Health & Science University Director, the Pacific
More informationPsychological and Legal Ramifications of High-Dose Opioids in Non-Cancer Pain
Psychological and Legal Ramifications of High-Dose Opioids in Non-Cancer Pain Binit J. Shah, MD, FAPA Ohio Hospital for Psychiatry Columbus, OH 614-449-9664 1 Binit J. Shah, Disclosures Financial o Medtronic,
More informationFollow-up Question and Answer Webinar: Advances in Recognition and Treatment of Substance Use Disorders in Primary Care
Follow-up Question and Answer Webinar: Advances in Recognition and Treatment of Substance Use Disorders in Primary Care Richard Ries, MD University of Washington June 12, 2015 1 Ries Disclosures Current
More informationUsing Treatment Agreements and Urine Drug Testing in Chronic Pain: Why, When, and How?
Using Treatment Agreements and Urine Drug Testing in Chronic Pain: Why, When, and How? Joanna L. Starrels, MD, MS Albert Einstein College of Medicine Montefiore Medical Center July 29, 2015 1 Disclosures
More informationDisclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond
Women and opioid use disorder: Optimizing care during pregnancy and beyond Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP Ashley L. Hodges, PhD, CRNP, WHNP-BC Disclosures Dr. Fogger has nothing to
More informationMotivational Interviewing in Managing Pain. Patricia Bruckenthal, PhD, APRN-BC, ANP, FAAN Stony Brook University School of Nursing
Motivational Interviewing in Managing Pain Patricia Bruckenthal, PhD, APRN-BC, ANP, FAAN Stony Brook University School of Nursing 1 Educational Objectives At the conclusion of this activity participants
More informationMedication for the Treatment of Addiction (MAT)
Medication for the Treatment of Addiction (MAT) Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical College at Thomas Jefferson University Terminology: Words Matter Medication
More informationStrategies for Federal Agencies
Confronting Pain Management and the Opioid Epidemic Strategies for Federal Agencies Over the past 25 years, the United States has experienced a dramatic increase in deaths from opioid overdose, opioid
More informationKRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH
KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH IF THESE MOMS REALLY CARED ABOUT THEIR BABIES, THEY WOULD JUST QUIT Those who can quit, often do Addiction
More informationScreening, Brief Intervention, and Referral to Treatment (SBIRT) for Substance Use Disorders in Primary Care
Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Substance Use Disorders in Primary Care Jeanne Manubay, MD New York State Psychiatric Institute, Columbia University 1 Jeanne Manubay,
More informationBrief History of Methadone Maintenance Treatment
METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what
More information10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities
10/26/15 Perspec'ves on maternal opioid use and abuse Dr. Rita J. Nutt Our Expectation Harsh Realities 1 Opioid Abuse and Dependence Statistics, 2013 4.5 million people in the US current non- medical users
More informationPain Medication and Adolescents: Special Considerations
Pain Medication and Adolescents: Special Considerations Patricia Cintra Franco Schram, MD Adolescent Substance Abuse Program Boston Children s Hospital Harvard Medical School 1 Educational Objectives At
More informationLearning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons
Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Marianna Corona Jennifer Foley September 12, 2017 Learning Objectives 2017 Improving Family Outcomes
More information2016 American Academy of Neurology
2016 American Academy of Neurology PCSS-O is a collaborative effort led by American Academy of Addiction Psychiatry (AAAP) in partnership with: Addiction Technology Transfer Center (ATTC), American Academy
More informationR. Gregory Lande, DO, FACN American Osteopathic Academy of Addiction Medicine
Integrated Management of Post Traumatic Stress Disorder (PTSD) and Opioid Use Disorders R. Gregory Lande, DO, FACN American Osteopathic Academy of Addiction Medicine 1 R. Gregory Lande, DO, FACN, Disclosures
More informationOpioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine
Opioid Use Disorders and Pregnancy Marcela Smid, MD Maternal-Fetal Medicine UNIVERSITY OF UTAH HEALTH, 2017 OBJECTIVES Definitions Epidemiology Pharmacology Effects on pregnancy Screening Treatment CARE
More informationOpioid use in pregnancy and Neonatal Abstinence Syndrome
Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,
More informationManaging Patients with Pain and Psychiatric Co-Morbidity. John A. Renner Jr., MD Division of Psychiatry Boston University School of Medicine
Managing Patients with Pain and Psychiatric Co-Morbidity John A. Renner Jr., MD Division of Psychiatry Boston University School of Medicine 1 Educational Objectives At the conclusion of this activity participants
More informationStress, Relaxation, and Mindful Breathing: A Primer. Kevin E. Vowles, Ph.D. University of New Mexico
Stress, Relaxation, and Mindful Breathing: A Primer Kevin E. Vowles, Ph.D. University of New Mexico 1 Educational Objectives At the conclusion of this activity participants should be able to: State the
More information2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society
Pregnant Women Who Use Drugs: Stigma, Science and Society Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia
More informationBest Practices: Eight Principles for Safer Opioid Prescribing
Best Practices: Eight Principles for Safer Opioid Prescribing Lynn R. Webster, MD Vice President of Scientific Affairs PRA International Salt Lake City, UT February 11, 2015 Dr Webster: Disclosures 12-Month
More informationAligning Evidence-Based Practices with CCBHC Financing, Operations, and Quality Reporting. October 25th, :00pm 3:00pm
Aligning Evidence-Based Practices with CCBHC Financing, Operations, and Quality Reporting October 25th, 2017 2:00pm 3:00pm Webinar Login Directions Recommend calling in on your telephone. Enter your unique
More information4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING
Opioid Use Disorder in Pregnancy 2017 Recommendations from ACOG and The Pew Charitable Trust KATHY D. HARTKE, MD, LEGISLATIVE CO-CHAIR AND IMMEDIATE PAST CHAIR, WISCONSIN SECTION OF THE AMERICAN COLLEGE
More informationObjectives/Agenda 2/17/2015. Nancy Wiedemer, RN, MSN, CRNP Disclosures. Improving Pain Management in the Department of Veterans Affairs Part 2:
Improving Pain Management in the Department of Veterans Affairs Part 2: Primary Care Based Support for Managing Chronic Opioid Therapy Nancy Wiedemer, RN,MSN,CRNP Pain Management Coordinator Philadelphia
More informationPublic Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids
Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids Background The American Society of Addiction Medicine (ASAM) is deeply committed
More informationOpioid Dependence and Buprenorphine Management
Opioid Dependence and Buprenorphine Management Kevin Kapila, MD Fenway Health Medical Director of Behavioral Health Instructor in Medicine Harvard Medical School Learning Objectives Understand the rationale
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National
More information2015 American Academy of Neurology
Prescribing Opioids for Pain in the Era of Changing Pain Management Guidelines Miroslav Misha Bačkonja, MD Department of Neurology University of Wisconsin, Madison Department of Neurology University of
More informationSerious Mental Illness and Opioid Use Disorder
Serious Mental Illness and Opioid Use Disorder Serious Mental Illness and Opioid Use Disorders Arthur Robin Williams, MD MBE Columbia University, Department of Psychiatry Nick Szubiak, MSW, LCSW Director,
More informationMaternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC
Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home
More informationChild Welfare and MOMS: Building Partnerships to Improve Care
Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly
More informationMedication Treatment and Opioid Use Disorder
Medication Treatment and Opioid Use Disorder Colleen T. LaBelle, MSN, RN-BC,CARN Program Director, Office-Based Addiction Treatment Director, STATE OBOT-B Boston Medical Center Disclosures I have no disclosures
More informationADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians
ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of
More informationMAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014
MAT for Opioid Dependence Methadone maintenance treatment (MMT) Buprenorphine/naloxone (suboxone) Buprenorhine/naloxone (BupNX) Buprenorphine SL Parenteral naltrexone (P-ntx) Oral naltrexone (ntx) MAT
More informationEpidemiologic Data on Opioid Use: Changing Problems
Epidemiologic Data on Opioid Use: Changing Problems 1 Goals 1 To bridge the pain world and addiction world 1. Pain and pain treatment a. Chronic pain affects an estimated 100 million Americans (1/3 of
More informationAdvancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance
Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical
More informationHELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES
HELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES Learning Objectives Identify approaches for transforming
More informationSC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC
SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationMaternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015
Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples
More informationConfronting the Opioid Epidemic: Suboxone in Primary Care
Confronting the Opioid Epidemic: Suboxone in Primary Care Kami Harless, MD 1 The Opioid Epidemic 2 The Opioid Epidemic 3 Washington Epidemic 4 King County Epidemic 5 King County Epidemic 6 Outline Opioid
More informationINTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia
The American Journal on Addictions, 27: 92 96, 2018 Copyright 2018 American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/ajad.12687 Brief Report: Treating Women
More informationArizona s Opioid Epidemic
Arizona s Opioid Epidemic Rise in Heroin Addiction and the Dangers of Fentanyl Sara Salek, MD Chief Medical Officer Shana Malone, MS Clinical Initiatives Project Manager 1 Disclosures None The National
More informationThe Naltrexone Conundrum: Naltrexone s Impact on Pain Management in the Perioperative Period
The Naltrexone Conundrum: Naltrexone s Impact on Pain Management in the Perioperative Period Brian A. Mirante, MD Case studies, test questions and content review completed by: Stephen A. Wyatt, DO American
More informationWhy do people use drugs? Why do so many people use drugs? What should we do?
Why do people use drugs? Why do so many people use drugs? What should we do? David Labby MD PhD Health Share of Oregon -- May 17, 2018 Learning Objectives 1. To increase understanding of societal determinants
More informationOpioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity
Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Holly Hills, Ph.D. June 13, 2017 Department of Mental Health Law and Policy Overview: Persons who have not been in
More information3/27/2019. Reducing Inpatient Opioid Consumption. Conflict of Interest. Educational Objectives
Reducing Inpatient Opioid Consumption Creating a Therapeutic Foundation with Breakthrough Analgesia Based on Patient Function Chad Dieterichs, MD Peggy Lutz, FNP-BC, RN-BC March 27, 2019 1 Conflict of
More informationOpioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard
Opioid Use in Pregnant Women and Prenatal Care Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard Objectives Summarize contextual and co-morbid factors observed among
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationGabapentin diversion and misuse: Data from law enforcement and substance users
Gabapentin diversion and misuse: Data from law enforcement and substance users Mance E. Buttram, PhD NDEWS Presents Webinar 14 March 2018 Objectives 1. Brief overview of gabapentin literature 2. Present
More informationOpioid Abuse Treatment in Pregnancy
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2015 Opioid Abuse Treatment in Pregnancy Catherine A. Suppan Follow this and additional works
More informationOpioid Use Disorder Treatment: Buprenorphine Treatment Basics
Opioid Use Disorder Treatment: Buprenorphine Treatment Basics Daniel Warren, MD Eastern Oregon Coordinated Care Organization Provider Forum on Chronic Noncancer Pain Management Pendleton, OR February 24,
More informationPregnancy, Opioid Addiction, and Care Issues in Virginia
Pregnancy, Opioid Addiction, and Care Issues in Virginia Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia
More informationPennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story
Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Sarah Sharfstein Kawasaki, MD Director of Addictions Services, Pennsylvania Psychiatric
More information2016 American Academy of Neurology
PCSS-O is a collaborative effort led by American Academy of Addiction Psychiatry (AAAP) in partnership with: Addiction Technology Transfer Center (ATTC), American Academy of Neurology (AAN), American Academy
More informationBuilding capacity for a CHC response to Ontario's Opioid Crisis
Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC
More informationTapering Buprenorphine in Patients with Opioid Use Disorders
Tapering Buprenorphine in Patients with Opioid Use Disorders David Fiellin, M.D. Yale University School of Medicine John Renner, M.D. Boston University School of Medicine 1 David Fiellin and John Renner
More informationThe Opioid Crisis: What Can Physicians Do About It?
The Opioid Crisis: What Can Physicians Do About It? Richard S. Schottenfeld, M.D. Professor and Chair, Department of Psychiatry and Behavioral Sciences 2018 Louis J. Kolodner Memorial Lecture Disclosures
More informationExpanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital
Expanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital August 28, 2018 Hosted by John A. Renner, Jr., MD, DLFAPA Professor of Psychiatry Boston University
More informationOpioid dependence and buprenorphine treatment
Opioid dependence and buprenorphine treatment David Roll, MD Revere Family Health, Cambridge Health Alliance Instructor in Medicine, Harvard Medical School Joji Suzuki MD Medical Director of Addictions
More informationTrends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville
Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted
More informationDisposal of Medicines, including Opioids with Your Patients
American Dental Association - Webinar March 29, 2017 Discussing Safe Use, Storage and Disposal of Medicines, including Opioids with Your Patients Deborah Davidson, Senior Director, Member Relations & Special
More informationTHE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA
THE OPIOID CRISIS DEFINING THE CRISIS KATHLEEN DUPPER, MD MEDICAL DIRECTOR, HUNTSVILLE RECOVERY 19 th Annual Perinatal Conference: The Opioid Crisis September 21, 2018 DEFINING THE CRISIS NUMBER OF OPIOID-RELATED
More informationDiscrimination & the Opioid Crisis
Discrimination & the Opioid Crisis Nick Szubiak, MSW, LCSW Director, Clinical Excellence in Addictions National Council for Behavioral Health Prepared By: Stephanie Pellitt, MPA and Vrushabh Shah, MPH
More informationImproving care for pregnant people with opioid use disorder in U.S. jails: Research to implement medication assisted treatment
Improving care for pregnant people with opioid use disorder in U.S. jails: Research to implement medication assisted treatment Carolyn Sufrin, MD, PhD Departments of Gyn/Ob and Health, Behavior & Society
More informationPROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing
PROJECT DOVE Improving Maternal and Neonatal Health Through Safer Opioid Prescribing PARTNERS SUPPORT Bureau of Justice Assistance, Department of Justice Rhode Island Opportunity Non-medical prescription
More informationMark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC
Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01
More informationCDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control
CDC Guideline for Prescribing Opioids for Chronic Pain Centers for Disease Control and Prevention National Center for Injury Prevention and Control THE EPIDEMIC Chronic Pain and Prescription Opioids 11%
More informationNeonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)
Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationTake Home Naloxone: Law Update and Considerations for Pharmacy Professionals
Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Clint Ross, PharmD, BCPP Clinical Pharmacy Specialist Psychiatry Residency Program Director Psychiatric Pharmacy Medical University
More informationDemystifying Buprenorphine Prescribing for Youth With Opioid Use Disorders. Providers Clinical Support System Opioid Therapies (PCSSO) CME 6/21/2017
Demystifying Buprenorphine Prescribing for Youth With Opioid Use Disorders Geetha A. Subramaniam MD, DFAACAP, DFAPA National Institute on Drug Abuse June 21, 2017 1 Providers Clinical Support System Opioid
More informationOpioid Review and MAT Clinic CDC Guidelines
1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are
More informationChronic Pain in Women and its Relationship to Opioid Addiction
Chronic Pain in Women and its Relationship to Opioid Addiction Advancing Addiction Science Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse OPIOIDS are Powerful Analgesics
More informationEI Leadership April 24, 2018
Early Childhood Community Partnerships to Support Families Struggling with SUD EI Leadership April 24, 2018 Setting the Stage The issue of young children impacted by substance use disorders in families
More informationThe Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth
The Opioid Epidemic and Youth Prescription Drug Abuse Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth Disclosures: I have no relevant financial relationships with the manufacturer(s)
More informationFrom Medicaid Transformation Approved Project Toolkit, June 2017
From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate
More informationRevised 9/30/2016. Primary Care Provider Pain Management Toolkit
Revised 9/30/2016 Primary Care Provider Pain Management Toolkit TABLE OF CONTENTS 1. INTRODUCTION Page 1 2. NON-OPIOID SERVICES &TREATMENTS FOR CHRONIC PAIN Page 2 2.1 Medical Services Page 2 2.2 Behavioral
More information